Share

The promising regenerative potential of pulsed electromagnetic fields toward tendon differentiation : a hamstring tendon explant culture study.

PAPER pubmed Bone & joint research 2026 In vitro study Effect: benefit Evidence: Low

Abstract

AIMS: Hamstring tendons are commonly used autografts for anterior cruciate ligament (ACL) reconstruction. They represent an optimal source for in vitro testing of new approaches that may improve tendon regeneration and, likely, ligamentization after ACL reconstruction. We assessed ex vivo, in a 3D explant culture, the anabolic effect of pulsed electromagnetic fields (PEMF) on hamstring tendons in an experimental setting as close as possible to that of common clinical applications, suggesting a potential new therapeutic strategy to improving tendon remodelling. METHODS: We exposed tendon explants from nine donors to PEMF for 21 days, eight hours/day, with an intensity similar to that used in clinical practice, and evaluated specific gene expression by immunofluorescence and quantitative reverse transcription polymerase chain reaction (qRT-PCR) analyses. RESULTS: Increased expression of tendon-related markers (scleraxis, collagen types I and VI) and important players of tenogenic differentiation (c-Fos and mammalian target of rapamycin) was evidenced by immunofluorescence analysis upon PEMF exposure and confirmed by qRT-PCR analysis. CONCLUSION: Our results demonstrate that PEMF enhances tendon differentiation, which suggests that PEMF exposure could have clinical relevance as a new non-invasive adjuvant treatment for improving the early phases of hamstring autograft remodelling after ACL reconstruction, as well as possibly for hastening the repair of injured tendons.

AI evidence extraction

At a glance
Study type
In vitro study
Effect direction
benefit
Population
hamstring tendon explants from nine donors
Sample size
9
Exposure
pulsed electromagnetic fields ยท 21 days, 8 hours/day
Evidence strength
Low
Confidence: 50% ยท Peer-reviewed: yes

Main findings

PEMF exposure increased expression of tendon-related and tenogenic differentiation markers in hamstring tendon explants, indicating enhanced tendon differentiation.

Outcomes measured

  • expression of tendon-related markers (scleraxis, collagen types I and VI)
  • expression of tenogenic differentiation markers (c-Fos, mammalian target of rapamycin)

Limitations

  • ex vivo explant culture may not fully replicate in vivo conditions
  • small sample size of nine donors
  • no direct clinical outcomes assessed
View raw extracted JSON
{
    "study_type": "in_vitro",
    "exposure": {
        "band": null,
        "source": "pulsed electromagnetic fields",
        "frequency_mhz": null,
        "sar_wkg": null,
        "duration": "21 days, 8 hours/day"
    },
    "population": "hamstring tendon explants from nine donors",
    "sample_size": 9,
    "outcomes": [
        "expression of tendon-related markers (scleraxis, collagen types I and VI)",
        "expression of tenogenic differentiation markers (c-Fos, mammalian target of rapamycin)"
    ],
    "main_findings": "PEMF exposure increased expression of tendon-related and tenogenic differentiation markers in hamstring tendon explants, indicating enhanced tendon differentiation.",
    "effect_direction": "benefit",
    "limitations": [
        "ex vivo explant culture may not fully replicate in vivo conditions",
        "small sample size of nine donors",
        "no direct clinical outcomes assessed"
    ],
    "evidence_strength": "low",
    "confidence": 0.5,
    "peer_reviewed_likely": "yes",
    "keywords": [
        "pulsed electromagnetic fields",
        "tendon differentiation",
        "hamstring tendon",
        "ACL reconstruction",
        "tendon regeneration",
        "in vitro"
    ],
    "suggested_hubs": []
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.